Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Alzinova AB logo — Swedish clinical stage biopharma company developing disease-...

Alzinova AB

Swedish clinical stage biopharma company developing disease-modifying treatments against Alzheimer's disease.

Founded 2011 Sweden Sweden 10 employees Grant Biotechnology, Health Care +1

General Information

Company Name Alzinova AB
Founded Year 2011
Location Sweden Sweden
Employees 10
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Alzinova AB. To contact Alzinova AB, visit alzinova.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Alzinova AB

Alzinova AB is a Swedish clinical-stage biopharma company developing treatments for Alzheimer’s disease by specifically targeting neurotoxic amyloid beta oligomers. The lead candidate, ALZ-101, is a therapeutic vaccine for the treatment of Alzheimer's. Alzinova’s proprietary AβCC peptide™ technology enables the development of disease-modifying therapies that has unique ability and precision to target the toxic amyloid-beta oligomers involved in the onset and progression of the disease. Alzheimer’s is one of the most common and devastating neurological diseases globally, with of the order of 40 million people afflicted today. In addition, the antibody ALZ-201 is in preclinical development, and the ambition is to expand the pipeline further.

No funding data available for Alzinova AB yet.

Alzinova AB Alternatives & Competitors

Alzinova AB vs
Connect Biopharma
Connect Biopharma United States

Global Clinical Stage Company Connecting Patients with Innovation for Life

Series C
30 employees
Biotechnology, Health Care
Alzinova AB vs
Mereo BioPharma
Mereo BioPharma United Kingdom

Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & o...

Post-IPO Equity
45 employees
Biopharma, Biotechnology

FAQ About Alzinova AB

Swedish clinical stage biopharma company developing disease-modifying treatments against Alzheimer's disease.
Alzinova AB was founded in 2011.
Alzinova AB is headquartered in Sweden.
Alzinova AB operates in Biotechnology, Health Care and Pharmaceutical.
Alzinova AB has approximately 10 employees.
Top alternatives and competitors to Alzinova AB include Connect Biopharma, Mereo BioPharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alzinova AB and Connect Biopharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Alzinova AB, https://bouncewatch.com/company/alzinova-ab, updated 7 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes